Study Comparing Graft Function in Renal Allograft Recepients Receiving Reduced or Standard Dose CsA With Sirolimus

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00518375
Recruitment Status : Completed
First Posted : August 20, 2007
Last Update Posted : August 20, 2007
Information provided by:
Wyeth is now a wholly owned subsidiary of Pfizer

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : May 2001